Brief Report: High Levels of CD47 Expression in Thymic Epithelial Tumors

Brief Report: High Levels of CD47 Expression in Thymic Epithelial Tumors

Introduction: CD47 is a tumor antigen that inhibits phagocytosis leading to immune evasion. Anti-CD47 therapy is a promising new immunotherapy across numerous tumor types, but it has not been tested in thymic epithelial tumors (TETs): thymomas and thymic carcinomas. TETs are rare tumors that are dif...

Full description

Bibliographic Details
Main Authors: Thomas Yang Sun, MD, MHS, Brandon Nguyen, BA, Simon B. Chen, MD, Yasodha Natkunam, MD, PhD, Sukhmani Padda, MD, Matt van de Rijn, MD, Robert West, MD, PhD, Joel W. Neal, MD, PhD, Heather Wakelee, MD, Jonathan W. Riess, MD, MS
Format: Article
Language:English
Published: Elsevier 2023-04-01
Series:JTO Clinical and Research Reports
Subjects:
CD47
Thymoma
Thymic carcinoma
Immunotherapy
Thymic epithelial tumor
Online Access:http://www.sciencedirect.com/science/article/pii/S2666364323000371

Internet

http://www.sciencedirect.com/science/article/pii/S2666364323000371

Similar Items